Empowering Drug Screening and Mechanism Studies with TR-FRET (Asia Pacific Session)

Trained as a scientist at the University of British Columbia, Dr. Sun has built a career around transforming cutting-edge science into commercially viable technologies. Known for her operational excellence and cross-functional leadership, Dr. Sun has led the successful delivery of reagent platforms that directly support faster IND filings and clinical readiness. Her career reflects a deep commitment to bridging scientific rigor with scalable product innovation - delivering impactful solutions that meet the evolving needs of therapeutic developers.

During the drug development process, researchers often encounter several key challenges:

- Cumbersome screening workflows: Traditional methods involve multiple steps, consuming significant time and effort.

- Poor data reproducibility: Results can be inconsistent and prone to background interference, making decision-making difficult.

- Limited throughput capacity: Conventional methods struggle to meet the efficiency needs of large-scale candidate screening and mechanistic studies.